Search results
Results from the WOW.Com Content Network
www.usp.org. The United States Pharmacopeia (USP) is a pharmacopeia (compendium of drug information) for the United States published annually by the over 200-year old United States Pharmacopeial Convention (usually also called the USP), a nonprofit organization that owns the trademark and also owns the copyright on the pharmacopeia itself.
A separate list for children up to 12 years of age, known as the WHO Model List of Essential Medicines for Children (EMLc), was created in 2007 and is in its 9th edition. [ 10 ][ 21 ][ 22 ][ 23 ] It was created to make sure that the needs of children were systematically considered such as availability of proper formulations. [ 24 ][ 25 ...
As a result of this regulation, 130 drugs have been withdrawn from the market, but drugs containing multicomponent dextromethorphan can be sold over the counter. [44] In its official press release, the bureau also stated that dextromethorphan is often used as a substitute for marijuana, amphetamine, and heroin by drug abusers, and its use as an ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
AbbVie: Humira ($14.4 billion) Humira is AbbVie's top-selling drug for arthritis. At $14.4 billion, it did bring in a lot of revenue in 2023 -- 27% of the company's overall sales. The drug's sales ...
Moxifloxacin is an antibiotic, used to treat bacterial infections, [4] including pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis. [4][5] It can be given by mouth, by injection into a vein, and as an eye drop. [5] Common side effects include diarrhea, dizziness, and headache. [4] Severe side effects may include spontaneous ...
June 2021. $1.7 billion. 53%. Zepbound (tirzepatide) November 2023. $1.2 billion. n/a. Source: Company filings. Currently, Ozempic remains atop the other GLP-1 drugs on this list, but the drug has ...
August 8, 2024 at 10:55 AM. By Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration has approved Citius Pharmaceuticals' therapy for patients with a form of blood cancer who have ...